Medical Equipment

Intravenous Fluid Transfer Drug Devices Market Growth Prospects 2026–2030 with Innovation Trends and Competitive Landscape

March 12, 2026March 12, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Intravenous Fluid Transfer Drug Devices Market By The End Of 2030?

The intravenous fluid transfer drug devices market size has seen robust growth in recent years. It is projected to increase from $7.85 billion in 2025 to $8.35 billion in 2026, progressing at a compound annual growth rate (CAGR) of 6.3%. The expansion observed in the historic period can be attributed to a reliance on conventional IV sets, an increase in hospital and clinical procedures, the limited availability of smart infusion devices, growing awareness of IV therapy benefits, and the adoption of PVC infusion bags.

The intravenous fluid transfer drug devices market is anticipated to show robust expansion over the next few years. It is expected to reach **$10.55 billion in 2030 at a compound annual growth rate (CAGR) of 6.0%.** This growth during the forecast period can be attributed to several factors including technological advancements in smart infusion pumps, a rising demand for pre-filled and multi-chamber infusion bags, increasing applications in oncology and neurology, the growth of home healthcare and ambulatory infusion, and stricter regulatory and quality standards. Major trends expected during this period include the rising adoption of smart infusion devices and pumps, increasing use of pre-filled and multi-chamber infusion bags, growing demand for needleless connectors and safety IV sets, the expansion of IV therapy across chronic and critical care treatments, and an enhanced focus on sterility, accuracy, and flow control.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19535&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Intravenous Fluid Transfer Drug Devices Market?

A projected increase in hospitalization rates is anticipated to fuel the expansion of the intravenous fluid transfer drug device market in the future. This surge in hospitalizations stems from factors such as an aging demographic, prevalent chronic conditions, sophisticated diagnostic tools, greater access to healthcare, as well as lifestyle-related health issues and progress in medical technology. For patients admitted to hospitals, fluid transfer systems facilitate the accurate and regulated delivery of fluids and medicines directly into their bloodstream. As an illustration, data from GOV.UK, a US-based government agency, indicated that in March 2023, COVID-19 hospital admissions within England saw a minor increase, reaching 10.62 per 100,000 in 2023, while ICU/HDU admissions remained minimal at 0.28 per 100,000. Most areas experienced modest rises, with admission rates generally consistent across various age demographics. Consequently, an elevated hospitalization rate is set to stimulate the growth of the intravenous fluid transfer drug device market.

Which Segment Classifications Shape The Intravenous Fluid Transfer Drug Devices Market?

The intravenous fluid transfer drug devices market covered in this report is segmented –

1) By Type: Infusion Bags, Infusion Devices, Other Types

2) By Application: Autoimmune Diseases, Blood Disorders, Cardiovascular Disorders, Neurology, Oncology, Other Applications

3) By End-Use Sector: Hospitals, Specialized Clinics, Other End-Use Sectors

Subsegments:

1) By Infusion Bags: PVC Infusion Bags, Non-PVC Infusion Bags, Pre-Filled Infusion Bags, Multi-Chamber Infusion Bags, IV Fluid Administration Bags

2) By Infusion Devices: Infusion Pumps, Syringe Pumps, Ambulatory Infusion Pumps, Gravity Infusion Devices, Smart Infusion Devices

3) By Other Types: IV Sets And Accessories, IV Catheters, Needleless Connectors, Flow Regulators, Pressure Infusion Devices

How Are Trends Impacting The Intravenous Fluid Transfer Drug Devices Market?

Major companies in the intravenous fluid transfer drug device market are actively developing modular and comprehensive infusion systems, incorporating features such as auto-identification to enhance accuracy, improve patient safety, and streamline the administration of fluids and medications. Auto-identification within these infusion systems functions by automatically verifying and matching medications to the correct patient, utilizing technologies such as barcode scanning or RFID. An instance of this progress is Becton, Dickinson, and Company, a US-based medical device company, which received FDA 510(k) clearance in July 2023 for its updated BD Alaris Infusion System. The BD Alaris Infusion System features updated hardware for its Point-of-Care Unit (PCU), including large volume pumps, syringe pumps, patient-controlled analgesia (PCA) pumps, respiratory monitoring, and auto-identification modules. Additionally, it introduces an advanced software version with enhanced cybersecurity and interoperability features, enabling seamless integration with widely used electronic medical record (EMR) systems, thereby fostering smart and connected healthcare.

Which Companies Are Expanding Their Footprint In The Intravenous Fluid Transfer Drug Devices Market?

Major companies operating in the intravenous fluid transfer drug devices market are Cardinal Health Inc., Medtronic plc, Becton Dickinson and Company, Baxter International Inc., B Braun Holding GmbH Co KG, Fresenius Kabi AG, Nipro Corporation, West Pharmaceutical Services Inc., ICU Medical Inc., Merit Medical Systems Inc., Vygon SAS, AngioDynamics Inc., Elcam Medical Inc., InfuSystem Holdings Inc., CODAN US Corporation, Arcomed AG, Terumo Corporation, Smiths Medical, IRadimed Corporation, Micrel Medical Devices SA, Boston Scientific Corporation, AdvaCare Pharma, Eitan Medical, Ypsomed Holding AG

Read the full intravenous fluid transfer drug devices market report here:

https://www.thebusinessresearchcompany.com/report/intravenous-fluid-transfer-drug-devices-global-market-report

Which Regions Are Projected To Dominate The Intravenous Fluid Transfer Drug Devices Market In The Coming Years?

North America was the largest region in the intravenous fluid transfer drug devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous fluid transfer drug devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Intravenous Fluid Transfer Drug Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19535&type=smp

Browse Through More Reports Similar to the Global Intravenous Fluid Transfer Drug Devices Market 2026, By The Business Research Company

Neurovascular Catheters Market Report 2026

https://www.thebusinessresearchcompany.com/report/neurovascular-catheters-global-market-report

Peripheral Iv Catheters Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-iv-catheters-global-market-report

Central Venous Catheters Market Report 2026

https://www.thebusinessresearchcompany.com/report/central-venous-catheters-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795